
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.0 | 1.1 | 0.0 |
Stocks | 99.1 | 99.1 | 0.0 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 27.2 | 24.0 |
Price to Book | 7.3 | 4.8 |
Price to Sales | 4.8 | 3.6 |
Price to Cash Flow | 20.8 | 16.5 |
Dividend Yield | 1.1 | 1.2 |
5 Years Earnings Growth | 13.2 | 12.2 |
Name | Net % | Category Average |
---|---|---|
Technology | 43.6 | 28.5 |
Consumer Cyclical | 16.5 | 12.6 |
Healthcare | 12.8 | 14.7 |
Financial Services | 11.3 | 14.4 |
Industrials | 7.2 | 12.1 |
Consumer Defensive | 4.2 | 6.3 |
Real Estate | 2.8 | 1.7 |
Communication Services | 1.6 | 9.1 |
Number of long holdings: 39
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 8.65 | 373.11 | -2.36% | |
Mastercard | US57636Q1040 | 7.91 | 530.55 | -3.07% | |
Amazon.com | US0231351067 | 7.73 | 178.41 | -8.98% | |
SAP | DE0007164600 | 6.86 | 238.950 | -4.07% | |
Eaton | IE00B8KQN827 | 4.95 | 260.85 | -8.10% | |
ADP | US0530151036 | 4.78 | 305.48 | -0.57% | |
Zoetis Inc | US98978V1035 | 4.07 | 159.61 | -2.38% | |
The Charles Schwab | US8085131055 | 3.29 | 74.87 | -4.73% | |
ASML Holding | NL0010273215 | 3.12 | 578.70 | -6.10% | |
Novo Nordisk B | DK0062498333 | 3.09 | 456.9 | -2.10% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
KSM KTF S&P 500 | 4.22B | -2.46 | 15.88 | - | ||
Kesem KTF SP500 Index Neutralized F | 2.08B | -0.45 | 8.92 | - | ||
IL0051289051 | 1.58B | -4.33 | 17.91 | - | ||
KESEM KTF Tel Aviv 125 | 1.04B | 4.74 | 7.35 | 6.59 | ||
Kesem KTF Nasdaq 100 Forex Neutral | 559.58M | -2.41 | 10.19 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review